Mylan raised the prices of 24 drug products more than 20 percent. One went up by 542 percent. Another by 444 percent. » Read More
Mylan has increased the price of the anti-allergy device EpiPen more than five-fold in recent years. » Read More
Two senior lawmakers on the U.S. Senate's Judiciary Committee pushed for information regarding sharp price increases for EpiPens. » Read More
Biotech stocks have underperformed the market but that could change as investors bet more deals could be in the making. » Read More
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.